These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 588901)

  • 21. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
    Konno N; Morikawa K
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to thyrotropin releasing hormone: an objective criterion for the adequacy of thyrotropin suppression therapy.
    Hoffman DP; Surks MI; Oppenheimer JH; Weitzman ED
    J Clin Endocrinol Metab; 1977 May; 44(5):892-901. PubMed ID: 404309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TSH suppression by octreotide in differentiated thyroid carcinoma.
    Maini CL; Sciuto R; Tofani A
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):335-9. PubMed ID: 8187297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early change of thyroid hormone concentration after 131I treatment in patients with solitary toxic adenoma.
    Pirnat E; Fidler V; Zaletel K; Gaberscek S; Hojker S
    Nuklearmedizin; 2002; 41(4):178-83. PubMed ID: 12224401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ACTH-stimulated glucocorticoid hypersecretion on the serum concentrations of thyroxine-binding globulin, thyroxine, triiodothyronine, reverse triiodothyronine and on the TSH-response to TRH.
    Bános C; Takó J; Salamon F; Györgyi S; Czikkely R
    Acta Med Acad Sci Hung; 1979; 36(4):381-94. PubMed ID: 233400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proceedings: Thyrotropin (TSH), thyroxine (T4) and triiodothyronine (T3) plasma levels in athyreotic adult patients : effects of L-T4 and prophylthiouracile (PTU) administration (author's transl)].
    Codaccioni JL; Carayon P; Jaquet P
    Ann Endocrinol (Paris); 1974; 35(6):674-5. PubMed ID: 4463817
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal.
    Vaiano A; Claudio Traino A; Boni G; Grosso M; Lazzeri P; Colato C; Davì MV; Francia G; Lazzeri M; Mariani G; Ferdeghini M
    Nucl Med Commun; 2007 Mar; 28(3):215-23. PubMed ID: 17264781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
    Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer.
    Burmeister LA; Goumaz MO; Mariash CN; Oppenheimer JH
    J Clin Endocrinol Metab; 1992 Aug; 75(2):344-50. PubMed ID: 1639933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism.
    Fisher DA; Schoen EJ; La Franchi S; Mandel SH; Nelson JC; Carlton EI; Goshi JH
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2722-7. PubMed ID: 10946871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rat model of the 131I-induced changes in thyroid function.
    Reilly CP; Symons RG; Wellby ML
    J Endocrinol Invest; 1986 Oct; 9(5):367-70. PubMed ID: 3794182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of thyrotropin, thyroid hormones and their response to thyrotropin releasing hormone in infective febrile illnesses.
    Talwar KK; Sawhney RC; Rastogi GK
    J Clin Endocrinol Metab; 1977 Feb; 44(2):398-403. PubMed ID: 402380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum thyroxine and triiodothyronine responses of hyperthyroid cats to thyrotropin.
    Mooney CT; Thoday KL; Doxey DL
    Am J Vet Res; 1996 Jul; 57(7):987-91. PubMed ID: 8807008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
    Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3.
    Burman KD; Dimond RC; Earll JM; Wright FD; Wartofsky L
    J Clin Endocrinol Metab; 1976 Sep; 43(3):606-13. PubMed ID: 989049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short and long term effects of radioiodine treatment on the iodine content of the thyroid gland.
    Schlumberger M; Fragu P; Hill C; Parmentier C; Tubiana M
    J Clin Endocrinol Metab; 1984 Nov; 59(5):893-8. PubMed ID: 6548226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of conventional L-thyroxine withdrawal and moderate hypothyroidism in preparation for whole-body 131-I scan and thyroglobulin testing.
    Marturano I; Russo M; Spadaro A; Latina A; Malandrino P; Regalbuto C
    J Endocrinol Invest; 2015 Sep; 38(9):1017-22. PubMed ID: 26070652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.